| Therapy Category | Targeted Therapy, Her2-Directed Therapy, Monoclonal Antibody |
|---|---|
| Protocols/Regimens | Tchp, Thp, Trastuzumab + Pertuzumab + Taxane, Maintenance Combinations |
| Primary Indications | Her2-Positive Early And Metastatic Breast Cancer, Her2-Positive Metastatic Gastric Cancer In Selected Combinations/Regions |
| Cancer/Tumor Types | Breast, Gastric/Gej |
| Salt / Active Composition | PERTUZUMAB |
| Strength / Dosage | 420 |
| Dosage Form | Injection |
| Prescription Required | Yes |